- Home
- ME vs ZTEK Comparison
ME vs ZTEK Comparison
Compare ME & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ME
- ZTEK
- Stock Information
- Founded
- ME 2006
- ZTEK 2008
- Country
- ME United States
- ZTEK Canada
- Employees
- ME N/A
- ZTEK N/A
- Industry
- ME Precision Instruments
- ZTEK Major Chemicals
- Sector
- ME Health Care
- ZTEK Industrials
- Exchange
- ME Nasdaq
- ZTEK Nasdaq
- Market Cap
- ME 98.7M
- ZTEK 116.6M
- IPO Year
- ME N/A
- ZTEK N/A
- Fundamental
- Price
- ME $2.75
- ZTEK $1.11
- Analyst Decision
- ME Hold
- ZTEK
- Analyst Count
- ME 1
- ZTEK 0
- Target Price
- ME $9.40
- ZTEK N/A
- AVG Volume (30 Days)
- ME 184.9K
- ZTEK 54.3K
- Earning Date
- ME 01-28-2025
- ZTEK 02-11-2025
- Dividend Yield
- ME N/A
- ZTEK N/A
- EPS Growth
- ME N/A
- ZTEK N/A
- EPS
- ME N/A
- ZTEK N/A
- Revenue
- ME $208,775,000.00
- ZTEK $29,132.00
- Revenue This Year
- ME $21.93
- ZTEK N/A
- Revenue Next Year
- ME $17.31
- ZTEK N/A
- P/E Ratio
- ME N/A
- ZTEK N/A
- Revenue Growth
- ME N/A
- ZTEK 8.15
- 52 Week Low
- ME $2.66
- ZTEK $0.50
- 52 Week High
- ME $16.52
- ZTEK $1.46
- Technical
- Relative Strength Index (RSI)
- ME 30.98
- ZTEK 53.58
- Support Level
- ME $3.25
- ZTEK $1.04
- Resistance Level
- ME $3.58
- ZTEK $1.17
- Average True Range (ATR)
- ME 0.25
- ZTEK 0.09
- MACD
- ME -0.06
- ZTEK -0.00
- Stochastic Oscillator
- ME 0.91
- ZTEK 68.23
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.